SIMILAR PATTERNS OF AMINO ACIDS FOR 3PHA_A_ACRA701_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fvp | FLAVOPROTEIN 390 (Photobacteriumphosphoreum) |
no annotation | 5 | ILE A 168ASP A 97ASP A 48PHE A 9HIS A 131 | None | 1.41A | 3phaA-1fvpA:undetectable | 3phaA-1fvpA:17.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nnh | ASPARAGINYL-TRNASYNTHETASE-RELATEDPEPTIDE (Pyrococcusfuriosus) |
PF00152(tRNA-synt_2) | 5 | ASP A 173ILE A 208ILE A 186ARG A 191ASP A 52 | None | 1.19A | 3phaA-1nnhA:undetectable | 3phaA-1nnhA:19.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1nnh | ASPARAGINYL-TRNASYNTHETASE-RELATEDPEPTIDE (Pyrococcusfuriosus) |
PF00152(tRNA-synt_2) | 5 | ASP A 173ILE A 208ILE A 186ASP A 206ASP A 52 | None | 1.35A | 3phaA-1nnhA:undetectable | 3phaA-1nnhA:19.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ftw | DIHYDROPYRIMIDINEAMIDOHYDROLASE (Dictyosteliumdiscoideum) |
PF01979(Amidohydro_1) | 5 | ASP A 21ILE A 38ILE A 35ASP A 395ARG A 393 | None | 1.45A | 3phaA-2ftwA:3.8 | 3phaA-2ftwA:21.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2g3n | ALPHA-GLUCOSIDASE (Sulfolobussolfataricus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 11 | ASP A 87ASP A 212ILE A 213ILE A 249TRP A 284ASP A 320ARG A 400TRP A 413ASP A 416PHE A 449HIS A 480 | BOG A2000 (-2.7A)NoneNoneNoneNoneNoneBOG A2000 (-3.1A)NoneBOG A2000 (-3.0A)NoneNone | 0.51A | 3phaA-2g3nA:42.7 | 3phaA-2g3nA:27.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2iic | ALPHA-11 GIARDIN (Giardiaintestinalis) |
no annotation | 5 | ASP A 89ILE A 220ILE A 99ASP A 95ARG A 254 | None | 1.20A | 3phaA-2iicA:undetectable | 3phaA-2iicA:19.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2x2i | ALPHA-1,4-GLUCANLYASE ISOZYME 1 (Gracilariopsislemaneiformis) |
PF01055(Glyco_hydro_31) | 8 | ASP A 239ASP A 412ASP A 553ARG A 649TRP A 662ASP A 665PHE A 698HIS A 731 | QPS A1050 (-2.5A)QPS A1050 (-3.2A)QPS A1050 (-3.1A)QPS A1050 (-3.2A)QPS A1050 (-4.6A)QPS A1050 (-2.7A)QPS A1050 (-4.3A)QPS A1050 (-4.3A) | 0.50A | 3phaA-2x2iA:26.9 | 3phaA-2x2iA:24.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 470ASP A 582ARG A 642TRP A 656ASP A 659PHE A 692HIS A 740 | None | 0.43A | 3phaA-2xvgA:33.6 | 3phaA-2xvgA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 470TRP A 511ASP A 659PHE A 692HIS A 740 | None | 0.99A | 3phaA-2xvgA:33.6 | 3phaA-2xvgA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xvg | ALPHA XYLOSIDASE (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | TRP A 471ASP A 582ARG A 642TRP A 656ASP A 659 | EDO A1997 ( 4.5A)NoneNoneNoneNone | 1.33A | 3phaA-2xvgA:33.6 | 3phaA-2xvgA:23.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | ASP A 203ASP A 327ILE A 328ILE A 364TRP A 406ASP A 443ARG A 526TRP A 539ASP A 542PHE A 575HIS A 600 | GOL A3001 (-2.6A)3CU A1001 (-2.7A)3CU A1001 ( 3.9A)3CU A1001 (-4.5A)None3CU A1001 (-2.7A)3CU A1001 ( 3.5A)3CU A1001 (-4.6A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A)3CU A1001 (-3.9A) | 0.45A | 3phaA-3cttA:35.5 | 3phaA-3cttA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 6 | ASP A 203ASP A 327ILE A 364ARG A 526ASP A 542PHE A 575 | GOL A3001 (-2.6A)3CU A1001 (-2.7A)3CU A1001 (-4.5A)3CU A1001 ( 3.5A)3CU A1001 ( 2.5A)3CU A1001 (-4.5A) | 1.44A | 3phaA-3cttA:35.5 | 3phaA-3cttA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ctt | MALTASE-GLUCOAMYLASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 5 | ASP A 542ASP A 366ILE A 364ILE A 328ASP A 203 | 3CU A1001 ( 2.5A)None3CU A1001 (-4.5A)3CU A1001 ( 3.9A)GOL A3001 (-2.6A) | 1.17A | 3phaA-3cttA:35.5 | 3phaA-3cttA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gtd | FUMARATE HYDRATASECLASS II (Rickettsiaprowazekii) |
PF00206(Lyase_1)PF10415(FumaraseC_C) | 5 | ASP A 403ILE A 395ILE A 181ARG A 402ASP A 451 | None | 1.16A | 3phaA-3gtdA:undetectable | 3phaA-3gtdA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3j9d | OUTER CAPSID PROTEINVP2 (Bluetonguevirus) |
PF00898(Orbi_VP2) | 5 | ILE A 176ILE A 670ASP A 669ARG A 695ASP A 111 | None | 1.27A | 3phaA-3j9dA:undetectable | 3phaA-3j9dA:22.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lpp | SUCRASE-ISOMALTASE (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | ASP A 231ASP A 355ILE A 356ILE A 392TRP A 435ASP A 472ARG A 555TRP A 568ASP A 571PHE A 604HIS A 629 | NoneTRS A6001 (-2.9A)TRS A6001 ( 4.0A)NoneTRS A6001 ( 4.6A)TRS A6001 (-3.2A)TRS A6001 ( 4.6A)NoneTRS A6001 ( 3.7A)TRS A6001 (-4.4A)TRS A6001 (-4.2A) | 0.40A | 3phaA-3lppA:37.6 | 3phaA-3lppA:24.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p8t | ASNS-LIKEASPARAGINYL-TRNASYNTHETASE RELATEDPROTEIN (Pyrococcusabyssi) |
PF00152(tRNA-synt_2) | 5 | ASP A 173ILE A 208ILE A 186ARG A 191ASP A 52 | None | 1.28A | 3phaA-3p8tA:undetectable | 3phaA-3p8tA:19.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3p8t | ASNS-LIKEASPARAGINYL-TRNASYNTHETASE RELATEDPROTEIN (Pyrococcusabyssi) |
PF00152(tRNA-synt_2) | 5 | ASP A 173ILE A 208ILE A 186ASP A 206ASP A 52 | None | 1.45A | 3phaA-3p8tA:undetectable | 3phaA-3p8tA:19.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 7 | ASP A 73ASP A 197ILE A 198ARG A 404ASP A 420PHE A 453HIS A 478 | NoneACR A 664 (-2.9A)ACR A 664 (-3.5A)ACR A 664 (-4.0A)ACR A 664 (-2.8A)ACR A 664 (-4.4A)ACR A 664 (-4.2A) | 1.38A | 3phaA-3pocA:62.4 | 3phaA-3pocA:99.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3poc | ALPHA-GLUCOSIDASE (Blautia obeum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 11 | ASP A 73ASP A 197ILE A 198ILE A 234TRP A 271ARG A 404TRP A 417ASP A 420LYS A 422PHE A 453HIS A 478 | NoneACR A 664 (-2.9A)ACR A 664 (-3.5A)NoneACR A 664 (-4.6A)ACR A 664 (-4.0A)ACR A 664 (-4.6A)ACR A 664 (-2.8A)NoneACR A 664 (-4.4A)ACR A 664 (-4.2A) | 0.36A | 3phaA-3pocA:62.4 | 3phaA-3pocA:99.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 6 | ASP A1157ASP A1279ILE A1280ASP A1526PHE A1559HIS A1584 | ACR A 1 (-2.6A)ACR A 1 (-3.2A)ACR A 1 (-4.1A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 1.36A | 3phaA-3topA:37.4 | 3phaA-3topA:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 11 | ASP A1157ASP A1279ILE A1280ILE A1315TRP A1355ASP A1420ARG A1510TRP A1523ASP A1526PHE A1559HIS A1584 | ACR A 1 (-2.6A)ACR A 1 (-3.2A)ACR A 1 (-4.1A)NoneACR A 1 (-4.4A)ACR A 1 (-3.6A)ACR A 1 (-2.9A)ACR A 1 (-4.5A)ACR A 1 (-2.8A)ACR A 1 (-4.3A)ACR A 1 (-3.9A) | 0.41A | 3phaA-3topA:37.4 | 3phaA-3topA:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3top | MALTASE-GLUCOAMYLASE, INTESTINAL (Homo sapiens) |
PF00088(Trefoil)PF01055(Glyco_hydro_31)PF16863(NtCtMGAM_N) | 5 | ASP A1526ASP A1317ILE A1315ILE A1280ASP A1157 | ACR A 1 (-2.8A)ACR A 1 ( 4.6A)NoneACR A 1 (-4.1A)ACR A 1 (-2.6A) | 1.07A | 3phaA-3topA:37.4 | 3phaA-3topA:24.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uug | MULTIPLESUGAR-BINDINGPERIPLASMIC RECEPTORCHVE (Agrobacteriumfabrum) |
PF13407(Peripla_BP_4) | 5 | ASP A 143ASP A 91ARG A 17TRP A 18ASP A 242 | BDP A 331 (-2.8A)BDP A 331 (-3.0A)BDP A 331 (-4.0A)BDP A 331 ( 4.9A)BDP A 331 (-2.7A) | 1.17A | 3phaA-3uugA:2.7 | 3phaA-3uugA:19.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 6 | ASP A 232ASP A 357ILE A 358ASP A 568PHE A 601HIS A 626 | ACR A1001 (-2.7A)ACR A1001 (-3.0A)ACR A1001 (-3.6A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 1.50A | 3phaA-3welA:42.1 | 3phaA-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 11 | ASP A 232ASP A 357ILE A 358ILE A 396TRP A 432ASP A 469ARG A 552TRP A 565ASP A 568PHE A 601HIS A 626 | ACR A1001 (-2.7A)ACR A1001 (-3.0A)ACR A1001 (-3.6A)ACR A1001 (-4.9A)ACR A1001 ( 4.6A)ACR A1001 (-3.2A)ACR A1001 (-3.0A)ACR A1001 (-4.8A)ACR A1001 (-2.7A)ACR A1001 (-4.3A)ACR A1001 (-4.1A) | 0.37A | 3phaA-3welA:42.1 | 3phaA-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wel | ALPHA-GLUCOSIDASE (Beta vulgaris) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16863(NtCtMGAM_N) | 5 | ASP A 568ASP A 398ILE A 396ILE A 358ASP A 232 | ACR A1001 (-2.7A)NoneACR A1001 (-4.9A)ACR A1001 (-3.6A)ACR A1001 (-2.7A) | 1.13A | 3phaA-3welA:42.1 | 3phaA-3welA:26.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4b9y | ALPHA-GLUCOSIDASE,PUTATIVE, ADG31B (Cellvibriojaponicus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF17137(DUF5110) | 8 | ASP A 299ILE A 341ASP A 412ARG A 463TRP A 477ASP A 480PHE A 513HIS A 540 | None | 0.49A | 3phaA-4b9yA:39.9 | 3phaA-4b9yA:24.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4iug | BETA-GALACTOSIDASE A (Aspergillusoryzae) |
PF01301(Glyco_hydro_35)PF10435(BetaGal_dom2)PF13363(BetaGal_dom3)PF13364(BetaGal_dom4_5) | 5 | ASP A 620ILE A 368ILE A 81ASP A 80ASP A 905 | None | 1.33A | 3phaA-4iugA:6.9 | 3phaA-4iugA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4r1d | UNCHARACTERIZEDPROTEIN (Pseudomonasaeruginosa) |
no annotation | 5 | ASP A 503ILE A 444ASP A 442ARG A 441ASP A 490 | None | 1.50A | 3phaA-4r1dA:undetectable | 3phaA-4r1dA:20.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ywh | ABC TRANSPORTERSOLUTE BINDINGPROTEIN (Actinobacillussuccinogenes) |
PF13407(Peripla_BP_4) | 5 | ASP A 158ASP A 113ARG A 39TRP A 40ASP A 245 | XYP A 401 (-2.8A)XYP A 401 (-3.3A)XYP A 401 (-3.9A)NoneXYP A 401 (-2.4A) | 1.15A | 3phaA-4ywhA:undetectable | 3phaA-4ywhA:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5aw4 | NA, K-ATPASE ALPHASUBUNIT (Squalusacanthias) |
PF00122(E1-E2_ATPase)PF00689(Cation_ATPase_C)PF00690(Cation_ATPase_N)PF13246(Cation_ATPase) | 5 | ASP A 933ILE A 998ILE A 857ASP A1002ARG A1006 | None | 1.40A | 3phaA-5aw4A:undetectable | 3phaA-5aw4A:20.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | ASP A 211TRP A 285ASP A 321ASP A 401PHE A 434 | None | 1.36A | 3phaA-5djwA:39.4 | 3phaA-5djwA:27.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5djw | ALPHA-GLUCOSIDASE II (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | TRP A 285ASP A 321ARG A 385ASP A 401PHE A 434 | None | 1.22A | 3phaA-5djwA:39.4 | 3phaA-5djwA:27.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 11 | ASP A 303ASP A 443ILE A 444ILE A 480TRP A 517ASP A 556ARG A 617TRP A 630ASP A 633PHE A 666HIS A 691 | NoneTRS A1001 (-2.9A)TRS A1001 ( 4.1A)NoneTRS A1001 ( 4.9A)TRS A1001 (-3.2A)TRS A1001 (-4.0A)NoneTRS A1001 (-2.8A)TRS A1001 (-4.5A)TRS A1001 (-4.0A) | 0.42A | 3phaA-5dkxA:39.8 | 3phaA-5dkxA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dkx | ALPHAGLUCOSIDASE-LIKEPROTEIN (Chaetomiumthermophilum) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF17137(DUF5110) | 5 | ASP A 443ILE A 444ILE A 480TRP A 517ASP A 482 | TRS A1001 (-2.9A)TRS A1001 ( 4.1A)NoneTRS A1001 ( 4.9A)None | 1.26A | 3phaA-5dkxA:39.8 | 3phaA-5dkxA:23.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7c | ALPHA-GLUCOSIDASE (Bacteroidesthetaiotaomicron) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 8 | ASP A 228ASP A 348ASP A 460ARG A 507TRP A 520ASP A 523PHE A 556HIS A 588 | None | 0.46A | 3phaA-5f7cA:34.0 | 3phaA-5f7cA:23.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7s | GLYCOSIDE HYDROLASEFAMILY 31 (Trueperellapyogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 6 | ASP A 467ARG A 516TRP A 529ASP A 532PHE A 565HIS A 591 | CA A 805 (-2.9A) CA A 805 ( 4.6A)None CA A 805 ( 4.6A)NoneNone | 0.56A | 3phaA-5f7sA:21.6 | 3phaA-5f7sA:23.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f7u | CYCLOALTERNAN-FORMING ENZYME (Listeriamonocytogenes) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2)PF16338(DUF4968)PF16990(CBM_35) | 5 | ARG A 614TRP A 627ASP A 630PHE A 663HIS A 689 | GLC A1116 (-2.8A)GLC A1117 (-4.6A)GLC A1117 (-2.7A)GLC A1116 (-4.6A)GLC A1117 (-4.1A) | 0.65A | 3phaA-5f7uA:35.0 | 3phaA-5f7uA:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 11 | ASP A 305ASP A 451ILE A 452ILE A 488TRP A 525ASP A 564ARG A 624TRP A 637ASP A 640PHE A 673HIS A 698 | None5GF A1021 (-2.0A)5GF A1021 (-3.6A)None5GF A1021 (-3.7A)5GF A1021 (-2.1A)5GF A1021 (-3.4A)5GF A1021 ( 4.6A)5GF A1021 (-2.6A)5GF A1021 (-3.6A)5GF A1021 (-4.0A) | 0.46A | 3phaA-5hjrA:36.6 | 3phaA-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 451ILE A 452ILE A 488TRP A 525ASP A 490 | 5GF A1021 (-2.0A)5GF A1021 (-3.6A)None5GF A1021 (-3.7A)5GF A1021 ( 4.6A) | 1.22A | 3phaA-5hjrA:36.6 | 3phaA-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hjr | NEUTRALALPHA-GLUCOSIDASE AB (Mus musculus) |
PF01055(Glyco_hydro_31)PF13802(Gal_mutarotas_2) | 5 | ASP A 640ASP A 305ARG A 624ASP A 564HIS A 492 | 5GF A1021 (-2.6A)None5GF A1021 (-3.4A)5GF A1021 (-2.1A)None | 1.50A | 3phaA-5hjrA:36.6 | 3phaA-5hjrA:25.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 7 | ASP A 441ASP A 553ARG A 613TRP A 627ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)EDO A1008 (-2.7A)EDO A1008 (-4.6A)NoneEDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 0.40A | 3phaA-5jouA:33.4 | 3phaA-5jouA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | ASP A 441TRP A 482ASP A 630PHE A 663HIS A 709 | EDO A1008 (-2.8A)NoneEDO A1008 (-3.0A)EDO A1008 (-4.3A)EDO A1008 (-4.0A) | 1.07A | 3phaA-5jouA:33.4 | 3phaA-5jouA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jou | ALPHA-XYLOSIDASEBOGH31A (Bacteroidesovatus) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF17137(DUF5110) | 5 | TRP A 442ASP A 553ARG A 613TRP A 627ASP A 630 | EDO A1008 (-3.7A)EDO A1008 (-2.7A)EDO A1008 (-4.6A)NoneEDO A1008 (-3.0A) | 1.39A | 3phaA-5jouA:33.4 | 3phaA-5jouA:23.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 5 | ASP A 282ASP A 404ILE A 441ASP A 616PHE A 649 | ACR A1015 (-2.6A)ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 (-2.7A)ACR A1015 (-4.3A) | 1.40A | 3phaA-5nn8A:36.1 | 3phaA-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nn8 | LYSOSOMALALPHA-GLUCOSIDASE (Homo sapiens) |
no annotation | 10 | ASP A 282ASP A 404ILE A 441TRP A 481ASP A 518ARG A 600TRP A 613ASP A 616PHE A 649HIS A 674 | ACR A1015 (-2.6A)ACR A1015 (-3.0A)ACR A1015 (-4.3A)ACR A1015 ( 4.6A)ACR A1015 (-3.1A)ACR A1015 (-3.1A)ACR A1015 (-4.8A)ACR A1015 (-2.7A)ACR A1015 (-4.3A)ACR A1015 (-4.0A) | 0.40A | 3phaA-5nn8A:36.1 | 3phaA-5nn8A:24.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x3j | GLYCOSIDE HYDROLASEFAMILY 31 (Kribbellaflavida) |
no annotation | 5 | ARG A 500TRP A 513ASP A 516PHE A 549HIS A 575 | GLC A 819 ( 2.9A)GLC A 822 ( 4.6A)GLC A 822 ( 2.8A)GLC A 822 ( 4.8A)GLC A 822 ( 4.0A) | 0.59A | 3phaA-5x3jA:31.4 | 3phaA-5x3jA:8.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 6 | ASP A 429ARG A 474TRP A 488ASP A 491PHE A 533HIS A 565 | None | 0.44A | 3phaA-5x7sA:21.7 | 3phaA-5x7sA:19.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5x7s | GLYCOSIDE HYDROLASEFAMILY 31ALPHA-GLUCOSIDASE (Paenibacillussp. 598K) |
PF01055(Glyco_hydro_31)PF16338(DUF4968)PF16990(CBM_35)PF17137(DUF5110) | 5 | ASP A 432ASP A 529ILE A 492ASP A 491ASP A 429 | None | 1.41A | 3phaA-5x7sA:21.7 | 3phaA-5x7sA:19.62 |